Genzyme Announces Appointment of Brendan Martin as General Manager for UK and Ireland
Genzyme, a Sanofi Company, announced the appointment of Brendan Martin as General Manager for UK and Ireland. Brendan will be responsible for all Genzyme’s commercial activities in the UK and Ireland and will report to Robin Kenselaar, Head of Genzyme EMEA.
Brendan joined Genzyme in 2002 and was responsible for establishing and developing Genzyme’s Lysosomal Storage Disorders business in Ireland. In 2007, he became Business Unit Director and, in 2010, Deputy General Manager for UK and Ireland. He will be leading Genzyme in the UK and Ireland which will now, as part of the Sanofi group, focus on rare inherited diseases and immune diseases.
Brendan’s appointment follows the decision of Paul Drohan, Senior Vice President and General Manager UK and Ireland, to leave Genzyme following a 17 year career with company to return to Canada and pursue other opportunities.
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.